SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Glenmark Pharma

Glenmark Pharma

BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Feb 28, 17:00
788.65
8.70 (+1.12%)
VOLUME 48,982
AVERAGE VOLUME
5-Day 68,434
10-Day 74,858
30-Day 67,062
VOLUME SHOCKER
5-Day 68,434
10-Day 74,858
30-Day 67,062
Prev. Close
779.95
Open Price
781.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 766.80 791.20
52 Wk Low/High 510.00 840.10
LIVE
NSE
Feb 28, 17:00
789.90
10.45 (+1.34%)
VOLUME 260,605
AVERAGE VOLUME
5-Day 910,475
10-Day 905,491
30-Day 702,554
VOLUME SHOCKER
5-Day 910,475
10-Day 905,491
30-Day 702,554
Prev. Close
779.45
Open Price
784.80
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
789.90 (390)
Today’s Low/High 756.00 792.45
52 Wk Low/High 507.10 841.00
Action in Glenmark Pharma

Glenmark
Sentimeter

89%11%
BUYSELL

89% of moneycontrol users recommend buying Glenmark. What's your call on Glenmark today?
Read 2 investor views

Consolidated
MARKET CAP (Rs Cr)
21,395.64
*P/E
42.13
*BOOK VALUE (Rs)
109.96
DIV (%)
200.00%
Market Lot
1
INDUSTRY P/E
26.16
*EPS (TTM)
18.72
*P/C
29.53
*PRICE/BOOK
7.17
DIV YIELD.(%)
0.25%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
28.02 new
DELIVERY AVERAGES
3-Day 48.98%
5-Day 50.08%
8-Day 47.18%
* Based on consolidated numbers
Track Glenmark on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

28 February 2015

buy

SKSMicrofin Feb Fut

Entry Price (Rs)

418.20

Exit Price (Rs)

424.00

Gain (Rs)

6.00

buy

KotakMahindra Feb Fut

Entry Price (Rs)

1,382.10

Exit Price (Rs)

1,408.00

Gain (Rs)

26.00

buy

JindalSteel Feb Fut

Entry Price (Rs)

200.00

Exit Price (Rs)

206.00

Gain (Rs)

6.00

buy

JSWSteel Feb Fut

Entry Price (Rs)

1,012.00

Exit Price (Rs)

1,023.00

Gain (Rs)

11.00

buy

ACC Feb Fut

Entry Price (Rs)

1,661.00

Exit Price (Rs)

1,673.50

Gain (Rs)

13.00

buy

JubilantFood Feb Fut

Entry Price (Rs)

1,694.00

Exit Price (Rs)

1,719.00

Gain (Rs)

25.00

buy

Lupin Feb Fut

Entry Price (Rs)

1,721.00

Exit Price (Rs)

1,745.50

Gain (Rs)

25.00

F&O Quote
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 552.95 781.00  
High Price 574.50 791.20  
Low Price 552.95 766.80  
Last Price 570.20 788.65 38.31
Volume 57,066 48,982 -14.17
Simple Moving Averages
Days BSE NSE
30 747.86 748.17
50 749.98 750.27
150 735.64 735.90
200 691.79 692.09

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Glenmark

News/Videos & Announcements
Videos
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
 Consolidated (Dec '14)
(Sep '14)
Net Sales 1,692.11 1,671.53
Other Income 2.13 0.97
PBDIT 267.79 336.19
Net Profit 114.76 165.00

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
(Sep '14)
(In Rs Cr)
Total Share Capital 27.12
Net Worth 2906.02
Total Debt 353.32
Net Block 448.52
Investments 1409.24
Net Current Assets 1318.28
Total Assets 3259.35
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 911.00 3.62 965.90 552.50 188,683.03
Lupin 1746.95 0.51 1754.90 928.80 78,500.90
Dr Reddys Labs 3349.65 2.29 3662.00 2250.00 57,071.25
Cipla 681.50 1.84 711.45 385.00 54,721.75
Cadila Health 1547.90 1.17 1760.00 928.20 31,693.02
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Mar' 14Dec' 13
Promoter48.3148.2948.2848.30
FII35.0734.3533.2333.13
DII5.896.857.807.51
Others10.7310.5110.6911.06
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road,
City
Mumbai
State
Maharashtra
Pin Code
400026
Tel. No.
022-40189999 022-40189879
Fax No.
022-40189986
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Telangana
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
Glenn Saldanha
Chairman & Managing Director
Rajesh Desai
Executive Director
Cherylann Pinto
Director - Corporate Affairs
D R Mehta
Non Executive Director
J F Ribeiro
Non Executive Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Nile Recommended on Oct 23rd 2014

Recommended price 186.00  |  Peak from reco 371.40 100.16%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Glenmark

Glenmark is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 21,395.64 crore.The company has reported a consolidated sales of Rs 1,692.11 crore and a Net Profit of Rs 114.76 crore for the quarter ended Dec 2014.

The company management includes Glenn Saldanha - Chairman & Managing Director, Rajesh Desai - Executive Director, Cherylann Pinto - Director - Corporate Affairs, D R Mehta - Non Executive Director, J F Ribeiro - Non Executive Director, N B Desai - Non Executive Director, Sridhar Gorthi - Non Executive Director, Brian W Tempest - Non Executive Director, Bernard Munos - Non Executive Director, B E Saldanha - Non Executive Director.

It is listed on the BSE with a BSE Code of 532296 and the NSE with an NSE Code of GLENMARK.

Its Registered office is at B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai,Maharashtra - 400026.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Glenmark